MEDIFAST INC Stock News

Medifast, a health and wellness company, has seen its stock price decline by 76% since 2021, despite its Optavia platform helping over 2 million customers with weight loss. The company's earning power

Small-cap breakout stocks offer plenty of robust upside opportunities, but only for the patient and the adventurous. As with practically anything in life, the greater the reward, the higher the risk.

ARCH, CSUAY and MED have been added to the Zacks Rank #5 (Strong Sell) List on June 26, 2023.

Dividend growth stocks can provide growing wealth over time to income investors and potentially promote share price appreciation. The article explores five dividend growth stocks for June: OneMain Hol

I view Medifast's traditional business model at increasing risk from the growing popularity of GLP-1-based drugs. Recent M&A activity within the industry provides an indication of the premium investor

Medifast ( MED , Financial) is a mission-driven company supporting health and well-being, helping its customers transform their lives by providing healthy living products and programs. The company has

In arguably a vast majority of cases, the concept of top safe high-yield dividend stocks represents an oxymoron. Stated differently, if you want robust passive income, you usually must concede your pr

Medifast is a leader in the weight loss industry with a growing customer base. However, Medifast's stock price has gradually declined in 2023.

Invest in high-quality stocks for the long term/mostly investment grade companies. The goal of this portfolio is to collect weekly dividend checks that cover my monthly expenses in retirement.

May started off on a bit of a sour note, with the broader indexes giving up some of their gains. Declining prices have helped push up dividend yields across the board as share prices fall.

Medifast's Q1 2023 EPS of $3.67 beats by $1.27 and revenue of $349M beats analysts' expectations by $29.5M. For Q2 2023, the company expects a ~25% decline in revenue and a ~50% decline in EPS.

Medifast's (MED) first-quarter 2023 results reflect lower sales on reduced Coach productivity and cost inflation. While earnings increase year over year.

Medifast, Inc. (NYSE:MED ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Steve Zenker - Vice President of Investor Relations Dan Chard - Chairman & Chief Executive Offic

Medifast's (MED) first-quarter performance is likely to reflect the adverse impacts of macroeconomic volatility and increased inflation.

April's 5 Dividend Growth Stocks With 6.30%+ Yields